Eksempler på brug af Pharmacokinetic data på Engelsk og deres oversættelser til Dansk
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
There are no pharmacokinetic data in children.
Nelarabine and ara-G are extensively distributed throughout the body based on combined Phase I pharmacokinetic data at nelarabine doses of 104 to 2,900 mg/ m2.
Pharmacokinetic data are not available in the elderly.
Special populations Paediatric patients(age below 18 years) No pharmacokinetic data are available in the paediatric population.
No pharmacokinetic data in black patients are available.
Shire will provide pharmacokinetic data from a cohort of elderly patients.
No pharmacokinetic data in elderly patients are available.
Paediatric patients: no pharmacokinetic data are available in patients below 18 years of age.
No pharmacokinetic data in haemodialysis patients are available.
There are no pharmacokinetic data in patients> 75 years.
Pharmacokinetic data has been obtained for abacavir and lamivudine alone.
There are no clinical or pharmacokinetic data in patients with severe hepatic impairment Child-Pugh class C.
Pharmacokinetic data have been obtained for lamivudine and abacavir alone.
Special populations No pharmacokinetic data are available in patients with impaired renal or hepatic function.
Pharmacokinetic data on duloxetine is limited in patients with mild or moderate renal impairment.
Comparisons to published pharmacokinetic data with ritonavir-enhanced amprenavir and saquinavir regimens are also described.
Pharmacokinetic data on temsirolmus and sirolimus are available in patients up to age 79 years.
Summary of pharmacokinetic data from study GS-US-177-0105.
The pharmacokinetic data in paediatric patients are limited.
No pharmacokinetic data are available in patients over 65 years of age.
No pharmacokinetic data are available in the paediatric population.
No pharmacokinetic data are available during hepatic transplant rejection.
No pharmacokinetic data are available in patients with hepatic or renal impairment.
Limited pharmacokinetic data are available in hypertensive children above one month of age see 5.2.
The pharmacokinetic data for these patients at various time points are shown in the following table.
No pharmacokinetic data are available for patients with severe hepatic cirrhosis Child-Pugh C.
The pharmacokinetic data for bevacizumab are available from eight clinical trials in patients with solid tumours.
Compared with pharmacokinetic data from adults with CRF where the same sampling duration was used.
Pharmacokinetic data indicate that given a similar dosage, children have twice the serum levels as adolescents.
The pharmacokinetic data of homocystinuric patients on long-term betaine supplementation are very similar to those of healthy volunteers.